BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve Asset

  August 5, 2025

   · 

  9 min read
• Press Releases

  Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

  August 5, 2025

   · 

  10 min read
• Press Releases

  Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)

  August 5, 2025

   · 

  8 min read
• Press Releases

  TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

  August 5, 2025

   · 

  7 min read
• Press Releases

  Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2025

  August 5, 2025

   · 

  2 min read
• Press Releases

  Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call

  August 5, 2025

   · 

  2 min read
• Press Releases

  Mallinckrodt Names Leslie Donato to Board of Directors

  August 5, 2025

   · 

  3 min read
• Press Releases

  Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization

  August 5, 2025

   · 

  10 min read
• Press Releases

  Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

  August 5, 2025

   · 

  11 min read
• Press Releases

  Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results

  August 5, 2025

   · 

  1 min read